Netherlands Pharmaceutical Market Growth, Size, Trends, Revenue, Share and Future Competition

Netherlands Pharmaceutical Market Size- By ATC/Therapeutic Class, By Mode of Dispensing- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Netherlands Pharmaceutical Market Size- By ATC/Therapeutic Class, By Mode of Dispensing- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Dec 2023 Report ID: PHAR2316 Pages: 1 - 107 Formats*:     
Category : Pharmaceutical
Netherlands Pharmaceutical Market Introduction and Overview 

According to SPER Market Research, the Netherlands Pharmaceutical Market is estimated to reach USD XX billion by 2033 with a CAGR of 6.11%.

The report includes an in-depth analysis of the Netherlands Pharmaceutical Market, including market size and trends, product mix, applications, and supplier analysis. A pharmaceutical is any medicine that is prescribed or utilised for therapeutic purposes. Pharmaceuticals are goods with drugs in them in precise quantities that can be administered to patients. People are become more and more conscious about their health and lives. This serves as the market's catalyst.

  • July 2022: A warning letter was sent by the US FDA to a Dutch manufacturer of APIs, or active pharmaceutical ingredients. It was given notice to implement stronger procedures for cleaning equipment and greater safety measures to avoid cross-contamination.
  • May 2022: The Netherlands-based pharmaceutical business Centrient Pharmaceuticals has declared that it has fully complied with the anti-microbial resistance industry alliance's strict Predicted No Effect Concentration (PNEC) discharge targets for the clean production of its whole line of oral antibiotic products.
netherlands-pharmaceutical-market
Market Opportunities and Challenges
The nation is ideally situated for biopharmaceutical operations, with top-notch research institutes, a highly educated workforce, a first-rate healthcare system, and a government that supports innovation. The rise in healthcare and medical spending in recent years is indicative of the great potential for new drug research, infrastructure development, and entry/expansion opportunities. Pharmaceutical firms' profitability is predicted to suffer as a result of the government's simultaneous measures to reduce the cost of pharmaceutical items. It is anticipated that the Netherlands would shortly bargain with pharmaceutical corporations to reduce the prices of drugs. As a result, growth in the market is predicted throughout the forecast period due to the aforementioned factors. 

The pharmaceutical market faces challenges such as a high failure rate and escalating development costs for new products, impeding overall growth. A significant hurdle is the scarcity of a skilled workforce, particularly for drugs requiring specialized expertise, confined to specific research organizations and medical equipment sectors. Fluctuating raw material prices further limit market expansion. Moreover, a widening talent gap is evident as the pharmaceutical workforce struggles to align skills with the demands of modern biopharma production, particularly in areas like automation, computer science, and process modelling. This unaddressed skills gap poses a potential threat to innovation within the industry.

netherlands-pharmaceutical-market


Market Competitive Landscape
There are multiple prominent firms in the somewhat fragmented pharmaceutical sector. Currently, a small number of the main competitors control the majority of the market share. Prominent entities are actively pursuing acquisitions and joint partnerships with other businesses in an effort to strengthen their market positions inside the nation. The major players in the Netherlands Pharmaceutical market include: Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Others.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy ATC/Therapeutic Class, By Mode of Dispensing
 Regions coveredEast Netherlands, North Netherlands, South Netherlands, West Netherlands
 Companies CoveredAbbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Others
COVID-19 Impact on Netherlands Pharmaceutical Market
Early on in the COVID-19 pandemic, a number of lockdown laws were implemented, which had a big effect on the market. As per a January 2021 PubMed Central publication, a cross-sectional study was conducted and the results indicated a significant effect of the COVID-19 pandemic on the logistic procedures and services provided by Dutch pharmacies. Pharmaceutical sales decreased as a result of the decline in these services. As a result, the market was originally significantly impacted by the COVID-19 pandemic. Nonetheless, the market under investigation is anticipated to increase steadily following the pandemic during the study's projected period.

Key Target Audience
  • Government Health Departments
  • Healthcare Professionals
  • Patients and Patient Advocacy Groups
  • Pharmaceutical Companies
  • Pharmacy Chains and Retailers
  • Research and Development Institutes
  • Others
Our in-depth analysis of the Netherlands Pharmaceutical Market includes the following segments:
By ATC/Therapeutic Class
  • Alimentary Tract and Metabolisma
  • Antiinfectives for Systemic Use
  • Antineoplastic and Immunomodulating Agents
  • Antiparasitic Products, Insecticides, and Repellents
  • Blood and Blood-forming Organs
  • Cardiovascular System
  • Dermatological Drugs
  • By Mode of Dispensing
  • OTC
  • Prescription
  • By Region
  • East Netherlands
  • North Netherlands
  • South Netherlands
  • West Netherlands
  • Key Topics Covered in the Report
    • Netherlands Pharmaceutical Market Size (FY’2023-FY’2033)
    • Overview of Netherlands Pharmaceutical Market
    • Segmentation of Netherlands Pharmaceutical Market By ATC/Therapeutic Class (Alimentary Tract and Metabolisma, Antiinfectives for Systemic Use, Antineoplastic and Immunomodulating Agents, Antiparasitic Products, Insecticides, and Repellents, Blood and Blood-forming Organs, Cardiovascular System, Dermatological Drugs, Genitourinary System and Reproductive Hormones, Musculoskeletal System, Nervous System, Respiratory System, Sensory Organs, Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins, Various ATC Structures)
    • Segmentation of Netherlands Pharmaceutical Market By Mode of Dispensing (OTC, Prescription)
    • Statistical Snap of Netherlands Pharmaceutical Market
    • Expansion Analysis of Netherlands Pharmaceutical Market
    • Problems and Obstacles in Netherlands Pharmaceutical Market
    • Competitive Landscape in the Netherlands Pharmaceutical Market
    • Impact of COVID-19 and Demonetization on Netherlands Pharmaceutical Market
    • Details on Current Investment in Netherlands Pharmaceutical Market
    • Competitive Analysis of Netherlands Pharmaceutical Market
    • Prominent Players in the Netherlands Pharmaceutical Market
    • SWOT Analysis of Netherlands Pharmaceutical Market
    • Netherlands Pharmaceutical Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Netherlands Pharmaceutical Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Netherlands Pharmaceutical Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Netherlands Pharmaceutical Market

    7. Netherlands Pharmaceutical Market, By ATC/Therapeutic Class (USD Million)
    7.1. Netherlands Pharmaceutical Market Value Share and Forecast, By ATC/Therapeutic Class, 2023-2033
    7.2. Alimentary Tract and Metabolisma 
    7.3. Antiinfectives for Systemic Use 
    7.4. Antineoplastic and Immunomodulating Agents
    7.5. Antiparasitic Products, Insecticides, and Repellents 
    7.6. Blood and Blood-forming Organs
    7.7. Cardiovascular System 
    7.8. Dermatological Drugs 
    7.9. Genitourinary System and Reproductive Hormones 
    7.10. Musculoskeletal System 
    7.11. Nervous System 
    7.12. Respiratory System 
    7.13. Sensory Organs 
    7.14. Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins
    7.15. Various ATC Structures 

    8. Netherlands Pharmaceutical Market, By Mode of Dispensing (USD Million)
    8.1. Netherlands Pharmaceutical Market Value Share and Forecast, By Mode of Dispensing, 2023-2033
    8.2. OTC 
    8.3. Prescription 

    9. Netherlands Pharmaceutical Market Forecast, 2019-2033 (USD Million)
    9.1. Netherlands Pharmaceutical Market Size and Market Share

    10. Netherlands Pharmaceutical Market, By ATC/Therapeutic Class, 2019-2033 (USD Million)
    10.1. Netherlands Pharmaceutical Market Size and Market Share By ATC/Therapeutic Class (2019-2026)
    10.2. Netherlands Pharmaceutical Market Size and Market Share By ATC/Therapeutic Class (2027-2033)

    11. Netherlands Pharmaceutical Market, By Mode of Dispensing, 2019-2033 (USD Million)
    11.1. Netherlands Pharmaceutical Market Size and Market Share By Mode of Dispensing (2019-2026)
    11.2. Netherlands Pharmaceutical Market Size and Market Share By Mode of Dispensing (2027-2033)

    12. Netherlands Pharmaceutical Market, By Region, 2019-2033 (USD Million)
    12.1. Netherlands Pharmaceutical Market Size and Market Share By Region (2019-2026)
    12.2. Netherlands Pharmaceutical Market Size and Market Share By Region (2027-2033)
    12.3. East Netherlands
    12.4. North Netherlands
    12.5. South Netherlands
    12.6. West Netherlands

    13. Company Profile
    13.1. Abbott Laboratories
    13.1.1. Company details
    13.1.2. Financial outlook
    13.1.3. Product summary 
    13.1.4. Recent developments
    13.2. AbbVie Inc.
    13.2.1. Company details
    13.2.2. Financial outlook
    13.2.3. Product summary 
    13.2.4. Recent developments
    13.3. Amgen Inc.
    13.3.1. Company details
    13.3.2. Financial outlook
    13.3.3. Product summary 
    13.3.4. Recent developments
    13.4. Astellas Pharma
    13.4.1. Company details
    13.4.2. Financial outlook
    13.4.3. Product summary 
    13.4.4. Recent developments
    13.5. AstraZeneca PLC
    13.5.1. Company details
    13.5.2. Financial outlook
    13.5.3. Product summary 
    13.5.4. Recent developments
    13.6. F. Hoffmann-La Roche AG
    13.6.1. Company details
    13.6.2. Financial outlook
    13.6.3. Product summary 
    13.6.4. Recent developments
    13.7. Johnson & Johnson
    13.7.1. Company details
    13.7.2. Financial outlook
    13.7.3. Product summary 
    13.7.4. Recent developments
    13.8. Merck & Co.
    13.8.1. Company details
    13.8.2. Financial outlook
    13.8.3. Product summary 
    13.8.4. Recent developments
    13.9. Novartis AG
    13.9.1. Company details
    13.9.2. Financial outlook
    13.9.3. Product summary 
    13.9.4. Recent developments
    13.10. Pfizer Inc.
    13.10.1. Company details
    13.10.2. Financial outlook
    13.10.3. Product summary 
    13.10.4. Recent developments
    13.11. Others 
     
    14. List of Abbreviations

    15. Reference Links

    16. Conclusion

    17. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Netherlands Pharmaceutical Market is projected to reach USD XX billion by 2033, growing at a CAGR of 6.11% during the forecast period.
    Netherlands Pharmaceutical Market from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 6.11% during the forecast period.
    Netherlands Pharmaceutical Market CAGR of 6.11% during the forecast period.
    Netherlands Pharmaceutical Market size is USD XX billion from 2023 to 2033.
    Hydration Containers Market is covered By ATC/Therapeutic Class, By Mode of Dispensing .
    The Europe is anticipated to have the highest market share in the Netherlands Pharmaceutical Market.
    The key players in the market include Companies Covered Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Others
    The nation is ideally situated for biopharmaceutical operations, with top-notch research institutes, a highly educated workforce, a first-rate healthcare system, and a government that supports innovation.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 2950
    • 20% off
               
      $ 3950
    • 25% off
           
      $ 5150
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650